Blood metabolites associated with earlier or later death in dogs broadly resembled signals identified in five large human mortality studies. The finding gives researchers another reason to study pet dogs as models of aging, but it does not offer owners a lifespan prediction or a diagnostic test.
The research, recently published in The Journals of Gerontology, examined blood samples from dogs enrolled in the Dog Aging Project. This nationwide, long-term study follows pet dogs living with owners across the United States.
Owners provide extensive survey information about their dogs’ lives, while a subset submits biological samples annually. The broader project has enrolled 51,000 dogs, and nearly 1,000 belong to a precision cohort that provides additional data and samples, according to UW Medicine.
A metabolic fingerprint, not a single warning sign
Metabolites are small chemicals and molecules created during normal bodily processes. Researchers analyzed thousands of them together, looking for combinations that formed a metabolic fingerprint associated with whether individual dogs died earlier or later.
Using mortality as the endpoint allowed the team to work backward and identify biological patterns that may deserve closer study. Potential areas include metabolism, inflammation and cellular responses to stress.
The researchers then compared the canine findings with five large human mortality studies that used similar metabolite-based methods. Across those studies, the signals associated with earlier or later death in people were broadly similar to the patterns identified in dogs.
“The molecules that are risky for dogs or protective against a sooner death are very similar to those in people, showing that we share important features of aging biology, which is really interesting and rewarding,” said Dr. Kate Creevy, chief veterinary officer for the Dog Aging Project and a professor in the Texas A&M College of Veterinary Medicine and Biomedical Sciences.
That similarity does not mean every molecule had an identical role in both species. It also does not establish that any identified biomarker caused a dog or person to die earlier or later.
“Importantly, those biomarkers do not necessarily cause an outcome; when we find a biomarker associated with sooner or later mortality, we don’t know that it’s causing it,” Creevy said.
Why pet dogs can help aging research
Dogs share many parts of daily life with people, including environments, diets and activity patterns. They also experience biological hallmarks of aging over a much shorter period, making long-term outcomes observable sooner than they generally are in human research.
Dogs typically live 12 to 13 years, while humans live into their 70s on average. Separate research described by the National Human Genome Research Institute also found that dogs and people share age-related biological changes, although the agency cautions that aging cannot be reduced to the familiar idea that one dog year always equals seven human years.
Pet dogs offer another practical advantage: They live in varied home settings rather than standardized laboratory environments. Information and samples supplied over time by participating owners can help researchers examine how biological patterns relate to real-life differences among dogs.
For owners, however, the new metabolic findings should not change care based on a blood marker. The analysis identified associations at the study level; it was not presented as a way to forecast an individual dog’s remaining lifespan or select a treatment.
Creevy’s practical guidance remains focused on a healthy diet and body weight while preserving mobility and cognitive health. Weight alone cannot distinguish fat from muscle, so the European Pet Food Industry Federation’s healthy-weight guidance recommends monitoring both weight and body condition and consulting a veterinarian for an assessment.
Owners who notice changes in weight, mobility, behavior or general health should seek veterinary guidance rather than interpret them through this research. Appropriate care depends on the individual dog’s age, body frame, health and activity level.
The cross-species similarities give researchers specific metabolic signals to investigate, including the biological mechanisms that might connect them with mortality. As Creevy characterized it, the work is a starting point rather than proof that changing a particular metabolite will extend life.
What would you do if your dog were in this situation? Share your thoughts in the comments.
By Sarah Mitchell — 8 years as a local-news reporter covering animal welfare, shelters, neighborhood disputes, and public-safety pet stories.
